Oxidative stress and inflammation have been recognized as important contributors to the risk of chronic non-communicable diseases. Intervention trials using EPA + DHA indicate benefit on CVD mortality and a significant inverse linear dose-response relationship has been found between EPA + DHA intake and CVD outcomes.
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
Read the full paper
Access the original peer-reviewed research via OpenAlex.
| Category | 🧬 Medicine & Biology |
| Published | Jul 15, 2021 |
| Journal | Nutrients |
| Authors | Ivana Djuričić, Philip C. Calder |
| DOI | 10.3390/nu13072421 |
| Citations | 970 |
| Source | OpenAlex |